Dr. Reddys Labs (RDY) – StreetInsider.com Reports
-
Dr. Reddy's Laboratories Ltd. (DRRD:IN) (RDY) PT Lowered to INR5,700 at Goldman Sachs
-
Dr. Reddy's Laboratories Ltd. (DRRD:IN) (RDY) PT Raised to INR6,690 at HSBC
-
Dr. Reddys Labs (RDY) Launches Versavo in the UK
-
Dr. Reddy's Laboratories (DRRD:IN) (RDY) PT Raised to INR6,499 at Nomura/Instinet
-
Dr. Reddy's Laboratories Ltd. (DRRD:IN) (RDY) PT Raised to INR6,785 at Investec
-
Dr. Reddy's Laboratories Ltd. (DRRD:IN) (RDY) PT Raised to INR6,310 at HSBC
-
Dr. Reddy's Laboratories Ltd. (DRRD:IN) (RDY) PT Raised to INR5,190 at JPMorgan
-
Jefferies Downgrades Dr. Reddy's Laboratories (RDY) to Underperform
-
Dr. Reddys Labs (RDY) Tops Q4 EPS by 10c
-
Dr. Reddy's Laboratories (RDY) PT Raised to $80 at Barclays
-
Dr. Reddy's Laboratories Ltd. (DRRD:IN) (RDY) PT Raised to INR6,220 at HSBC
-
Dr. Reddy's Laboratories (DRRD:IN) (RDY) PT Raised to INR6,400 at Macquarie
-
Jefferies Downgrades Dr. Reddy's Laboratories Ltd. (DRRD:IN) (RDY) to Underperform
-
Dr. Reddys Labs (RDY) Acquires MenoLabs
-
Coya Therapeutics (COYA) and Dr. Reddy’s Laboratories Enter into Exclusive Collaboration for Development and Commercialization of COYA 302
-
Dr. Reddy's Laboratories (RDY) PT Raised to $75 at Barclays
-
Dr. Reddy's Laboratories Ltd. (DRRD:IN) (RDY) PT Lowered to INR6,065 at HSBC
-
Dr. Reddy's Laboratories Ltd. (DRRD:IN) (RDY) PT Lowered to INR5,121 at Bernstein
-
Dr. Reddy's Laboratories Ltd. (DRRD:IN) (RDY) PT Lowered to INR6,250 at Jefferies
-
Dr. Reddy's Laboratories Ltd. (DRRD:IN) (RDY) PT Raised to INR5,010 at Citi
-
Dr. Reddy's Laboratories Ltd. (DRRD:IN) (RDY) PT Raised to INR4,610 at JPMorgan
-
Dr. Reddy's Laboratories Ltd. (DRRD:IN) (RDY) PT Raised to INR5,375 at Kotak
-
Dr. Reddy's Laboratories Ltd. (DRRD:IN) (RDY) PT Raised to INR5,575 at Goldman Sachs
-
Dr. Reddys Labs (RDY) Tops Q3 EPS by 19c
-
Dr. Reddy's Laboratories Ltd. (DRRD:IN) (RDY) PT Raised to INR5,500 at Goldman Sachs
-
HSBC Downgrades Dr. Reddy's Laboratories Ltd. (DRRD:IN) (RDY) to Hold
-
Dr. Reddy's Laboratories (DRRD:IN) (RDY) PT Raised to INR6,300 at Macquarie
-
Nomura/Instinet Downgrades Dr. Reddy's Laboratories Ltd. (DRRD:IN) (RDY) to Neutral
-
Dr. Reddy's Laboratories Ltd. (DRRD:IN) (RDY) PT Raised to INR4,450 at JPMorgan
-
Dr. Reddy's Laboratories Ltd. (DRRD:IN) (RDY) PT Raised to INR6,330 at Jefferies
-
Dr. Reddy's Laboratories Ltd. (DRRD:IN) (RDY) PT Raised to INR6,000 at BofA Securities
-
Dr. Reddy's Laboratories Ltd. (DRRD:IN) (RDY) PT Raised to INR5,125 at Kotak
-
Dr. Reddy's Laboratories Ltd. (DRRD:IN) (RDY) PT Raised to INR5,075 at Goldman Sachs
-
Dr. Reddy's Laboratories Ltd. (DRRD:IN) (RDY) PT Raised to INR4,450 at JPMorgan
-
Dr. Reddy's Laboratories Ltd. (DRRD:IN) (RDY) PT Raised to INR4,900 at Citi
-
Dr. Reddy's Laboratories Ltd. (DRRD:IN) (RDY) PT Raised to INR6,150 at HSBC
-
Dr. Reddy's Laboratories Ltd. (DRRD:IN) (RDY) PT Raised to INR4,800 at Kotak
-
Dr. Reddys Labs (RDY) option implied volatility low
-
Dr. Reddys Labs (RDY) option implied volatility at low end of range
-
Dr. Reddy's Laboratories Ltd. (DRRD:IN) (RDY) PT Raised to INR5,500 at BofA Securities
-
Dr. Reddy's Laboratories (RDY) PT Raised to $70 at Barclays
-
Bernstein Downgrades Dr. Reddy's Laboratories Ltd. (DRRD:IN) (RDY) to Market Perform
-
Dr. Reddy's Laboratories (DRRD:IN) (RDY) PT Lowered to INR3,780 at JPMorgan
-
Dr. Reddy's Laboratories Ltd. (DRRD:IN) (RDY) PT Raised to INR4,300 at Credit Suisse
-
Dr. Reddy's Laboratories Ltd. (DRRD:IN) (RDY) PT Raised to INR5,171 at Morgan Stanley
-
Dr. Reddy's Laboratories Ltd. (DRRD:IN) (RDY) PT Raised to INR5,560 at HSBC
-
Citi Downgrades Dr. Reddy's Laboratories Ltd. (DRRD:IN) (RDY) to Sell
-
Dr. Reddy's Laboratories Ltd. (DRRD:IN) (RDY) PT Raised to INR5,600 at Jefferies
-
Dr. Reddy's Laboratories Ltd. (DRRD:IN) (RDY) PT Raised to INR5,220 at BofA Securities
-
Dr. Reddys Labs (RDY) Misses Q1 EPS by 89c
Back to RDY Stock Lookup